Kashiwagi T, Takazawa Y, Kagawa T, Taga T
Inflamm Regen. 2023; 43(1):8.
PMID: 36726165
PMC: 9893632.
DOI: 10.1186/s41232-022-00254-2.
Akindona F, Frederico S, Hancock J, Gilbert M
Front Oncol. 2022; 12:947634.
PMID: 36091174
PMC: 9454306.
DOI: 10.3389/fonc.2022.947634.
Sohn E
J Ovarian Res. 2022; 15(1):97.
PMID: 35978436
PMC: 9382745.
DOI: 10.1186/s13048-022-01014-z.
Jaramillo-Rangel G, Chavez-Briones M, Ancer-Arellano A, Ortega-Martinez M
Cells. 2021; 10(12).
PMID: 34943921
PMC: 8700449.
DOI: 10.3390/cells10123413.
Narayanan S, Wu Z, Wang J, Ma H, Acharekar N, Koya J
Int J Biol Sci. 2021; 17(10):2652-2665.
PMID: 34326700
PMC: 8315011.
DOI: 10.7150/ijbs.61229.
Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer.
Hassn Mesrati M, Behrooz A, Abuhamad A, Syahir A
Cells. 2020; 9(5).
PMID: 32429463
PMC: 7291262.
DOI: 10.3390/cells9051236.
Signaling pathways involved in chronic myeloid leukemia pathogenesis: The importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells.
Moradi F, Babashah S, Sadeghizadeh M, Jalili A, Hajifathali A, Roshandel H
Iran J Basic Med Sci. 2019; 22(6):581-589.
PMID: 31231484
PMC: 6570743.
DOI: 10.22038/ijbms.2019.31879.7666.
Co-expression of CD44/MyD88 is a poor prognostic factor in advanced epithelial ovarian cancer.
Zhu Y, Zhang H, Zhang G, Shi Y, Huang J
Ann Transl Med. 2019; 7(5):91.
PMID: 31019941
PMC: 6462660.
DOI: 10.21037/atm.2019.01.28.
Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav A, Desai N
Stem Cell Rev Rep. 2019; 15(3):331-355.
PMID: 30993589
DOI: 10.1007/s12015-019-09887-2.
Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives.
Raposo C
J Clin Transl Res. 2019; 3(2):233-249.
PMID: 30873475
PMC: 6410669.
Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4).
Deshmukh A, Arfuso F, Newsholme P, Dharmarajan A
Cancers (Basel). 2018; 10(2).
PMID: 29385093
PMC: 5836072.
DOI: 10.3390/cancers10020040.
Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.
Cha S, Choi Y, Hwang S, Jeong J, An H
J Cancer. 2017; 8(17):3538-3547.
PMID: 29151939
PMC: 5687169.
DOI: 10.7150/jca.20348.
Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy.
Radpour R
World J Stem Cells. 2017; 9(10):169-178.
PMID: 29104735
PMC: 5661129.
DOI: 10.4252/wjsc.v9.i10.169.
Expression and function of ABCG2 and XIAP in glioblastomas.
Emery I, Gopalan A, Wood S, Chow K, Battelli C, George J
J Neurooncol. 2017; 133(1):47-57.
PMID: 28432589
PMC: 5627495.
DOI: 10.1007/s11060-017-2422-z.
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W, Alkarim S, Alhejin A, Mukhtar H, Saini K
Oncotarget. 2016; 7(46):76337-76353.
PMID: 27486983
PMC: 5342819.
DOI: 10.18632/oncotarget.10942.
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy.
Huang G, Xu Q, Cui Y, Li N, Bian X, Lv S
Cancer Sci. 2016; 107(5):583-9.
PMID: 27171351
PMC: 4970825.
DOI: 10.1111/cas.12925.
Cancer stem cells, metabolism, and therapeutic significance.
Yang M, Liu P, Huang P
Tumour Biol. 2016; 37(5):5735-42.
PMID: 26864589
DOI: 10.1007/s13277-016-4945-x.
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.
Chiurillo M
World J Exp Med. 2015; 5(2):84-102.
PMID: 25992323
PMC: 4436943.
DOI: 10.5493/wjem.v5.i2.84.
Nestin as a marker of cancer stem cells.
Neradil J, Veselska R
Cancer Sci. 2015; 106(7):803-11.
PMID: 25940879
PMC: 4520630.
DOI: 10.1111/cas.12691.
The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?.
Plaks V, Kong N, Werb Z
Cell Stem Cell. 2015; 16(3):225-38.
PMID: 25748930
PMC: 4355577.
DOI: 10.1016/j.stem.2015.02.015.